RNA aptamers in sepsis therapy
Aptamers are special nucleic acids with structural characteristics which allow them to bind to a specific protein as a target molecule. Selected RNA aptamers with a characteristic lead structure already exist, which bind specifically to the murine, lipopolysaccharide-binding protein (mLBP). This protein LBP plays a key role during septic shock and is linked to the LPS-induced signalling cascade. The selected RNA aptamers constitute valuable molecular tools in sepsis research and fulfil the preconditions for the development of new diagnostic and therapeutic medicines for the treatment of septic shock.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Security vulnerability in browser interface
… allows computer access via graphics card. Researchers at Graz University of Technology were successful with three different side-channel attacks on graphics cards via the WebGPU browser interface. The attacks…
A closer look at mechanochemistry
Ferdi Schüth and his team at the Max Planck Institut für Kohlenforschung in Mülheim/Germany have been studying the phenomena of mechanochemistry for several years. But what actually happens at the…
Severe Vulnerabilities Discovered in Software to Protect Internet Routing
A research team from the National Research Center for Applied Cybersecurity ATHENE led by Prof. Dr. Haya Schulmann has uncovered 18 vulnerabilities in crucial software components of Resource Public Key…
